CEFEPIME

Trials studying CEFEPIME

• phase3P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant Enterobacteralescompletedn=126
• phase2PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONINcompletedn=100
• phase3Efficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imipenem/Cilastatin in Subjects With Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritiscompletedn=614
• phase3Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)completedn=530
• phase1A Single-center, Open-label, Study Evaluating Safety and Pharmacokinetics of Single Doses of Zidebactam-Cefepime and Metronidazole Alone or in Combination.completedn=30
• phase1Safety and Intrapulmonary Pharmacokinetics of Cefepime and Taniborbactam in Healthy Subjectscompletedn=30
• phase3Cefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABPwithdrawn
• phase3Safety and Efficacy Study of Cefepime/VNRX-5133 in Patients With Complicated Urinary Tract Infectionscompletedn=661